Acute myeloid leukaemia

C3_AML

acute myeloid leukemia: Acute myeloid leukemia (AML) is a group of neoplasms arising from precursor cells committed to the myeloid cell-line differentiation. All of them are characterized by clonal expansion of myeloid blasts. AML manifests by fever, pallor, anemia, hemorrhages and recurrent infections.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector
diagram bullet

Check conditions

HLP_C3_AML

222

diagram downward connector
diagram bullet

Filter registries

Cause of death: ICD-10 C92.0
Cause of death: ICD-9 2050A
Cause of death: ICD-8 20500
Cancer registry: Topography ICD-O-3 ANY
Cancer registry: Morphology ICD-O-3 9840|9861|986[67]|987[1-4]|989[1567]|9910|9920|993[01]
Cancer registry: Behaviour codes 3

222

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions C.O.D: 10, 8, 9

222

diagram downward connector

Check minimum number of events None

222

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

222

diagram downward connector
C3_AML

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF8

Summary Statistics

Key figures

All Female Male
Number of individuals 222 89 133
Unadjusted prevalence (%) 0.06 0.04 0.08
Mean age at first event (years) 59.23 52.23 63.92

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: C3_AML – Acute myeloid leukaemia
GWS hits:

Survival analyses between endpoints

Plot

before Acute myeloid leukaemia
after Acute myeloid leukaemia

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Acute myeloid leukaemia